Stocks Eye Daily, Weekly Drops as Omicron Variant Spreads

Investors are digesting mixed employment data for November, too

Digital Content Manager
Dec 3, 2021 at 12:19 PM
facebook twitter linkedin

This morning's rally was short lived. The major indexes are headed toward both daily and weekly losses at midday, as new cases of the Covid-19 omicron variant continue to pop up across the globe. The Dow Jones Industrial Average (DJI) is down 167 points, while the S&P 500 (SPX) and Nasdaq Composite (IXIC) are both swimming in red ink as well.

It's been a volatile week for reopening stocks, which are struggling once again today. News that Chinese ride-sharing giant Didi Global (DIDI) will be delisting from the New York Stock Exchange (NYSE) is also weighing on the market. In terms of economic indicators, nonfarm payrolls showed a worse-than-expected 210,000 jobs added in November, while the unemployment rate fell below analysts' estimates to 4.2%.

Continue reading for more on today's market, including: 

  • EV stock feeling the heat after Didi Global's delisting news.
  • Chip name's beat-and-raise sent analysts into a frenzy. 
  • Plus, options bulls target UPST; CYAD surges on private placement; and why CELZ is plummeting.

MMC Stats 1203

Upstart Holdings Inc (NASDAQ:UPST) is seeing an uptick in bullish options activity today, with volume running at nearly double the intraday average. So far, 35,000 calls have exchanged hands, compared to 16,000 puts. Most popular is the weekly 12/3 190-strike call, which expires later today, followed by the 200-strike call in that same series, with new positions being opened at both. UPST is down 2.4% at $172.80 at last check, struggling to find its footing at the newly formed 200-day moving average. The stock is up 324.2% in 2021. 

upst chart dec 3

One of the best stocks on the Nasdaq today is Celyad Oncology ADR (NASDAQ:CYAD), last seen up 44.6% at $5.15, after the company signed an agreement with Fortress Investment Group for a private placement worth $32.5 million, or 6.5 million ordinary shares at $5 each. CYAD hit a five-month high earlier today, and is now pacing for its best day in roughly three years, though it still sports a 32.7% year-to-date deficit. 

Creative Medical Technology Holdings Inc (NASDAQ:CELZ) is one of the worst-performing stocks on the Nasdaq, down 28.1% at $2.30 at last glace. Weighing on the security is news that the firm announced an underwritten public offering of 3.87 million shares priced at $4.13 per share. CELZ is down 83.4% year-to-date, and is eyeing its lowest close in nearly one year. 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners